Publication:
Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study

Placeholder

Organizational Units

Program

Institution Authors

Authors

Akgun, Zuleyha
Saglam, Sezer
Yucel, Serap
Gural, Zeynep
Balik, Emre
Cipe, Gokhan
Yildiz, ŞEYMA
Kilickap, Sadettin
Okyar, Alper
Kaytan-Saglam, Esra

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

The aim of this study was to evaluate efficacy and safety of chronomodulated capecitabine administered according to a specific time schedule (Brunch Regimen: Breakfast and Lunch) as a part of neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.

Description

Source:

Keywords:

Keywords

Citation

Akgun Z., Saglam S., Yucel S., Gural Z., Balik E., Cipe G., Yildiz Ş., Kilickap S., Okyar A., Kaytan-Saglam E., -Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study-, CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.74, ss.751-756, 2014

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details


Sustainable Development Goals

Thumbnail Image
Goal